title: [Adrenoreactivity in patients with arrhythmic syndrome associated with connective tissue dysplasia at the background of intake of the magnezium orotate].
abstract: Elevated level of -adrenoreception of membranes is observed in patients with disturbances of heart rhythm at the background of connective tissue dysplasia. It is not related to characteristics of the arrhythmic syndrome. At the background of 4-months intake of preparation magnezium orotate significant decrease of degree of desensitization of of erythrocytes has been noted.
authors.forename: Iu V
authors.initials: IuV
authors.lastname: Moskvina
authors.forename: G I
authors.initials: GI
authors.lastname: Nechaeva
mesh_terms: D000328:Adult; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control*; D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000009:adverse effects; D002395:Catecholamines / Q000378:metabolism; D003240:Connective Tissue Diseases / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D004910:Erythrocyte Membrane / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D009963:Orotic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D011943:Receptors, Adrenergic, beta / Q000378:metabolism; D013564:Sympathetic Nervous System / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D002316:Cardiotonic Agents; D002395:Catecholamines; D011943:Receptors, Adrenergic, beta; D009963:Orotic Acid; C104468:magnesium orotate